<?xml version="1.0" ?>
<document id="b708da1945a7a42cd61526e043d527592d4d9518">
  <chunk id="b708da1945a7a42cd61526e043d527592d4d9518.c0" text="Charge-Surrounded Pockets and Electrostatic Interactions with Small Ions Modulate the Activity of Retroviral Fusion Proteins">
    <entity charOffset="68-72" id="b708da1945a7a42cd61526e043d527592d4d9518.c0.e0" ontology_id="CHEBI_24870" text="Ions" type="chemical"/>
    <entity charOffset="116-124" id="b708da1945a7a42cd61526e043d527592d4d9518.c0.e1" ontology_id="CHEBI_36080" text="Proteins" type="chemical"/>
  </chunk>
  <chunk id="b708da1945a7a42cd61526e043d527592d4d9518.c1" text="Refolding of viral class-1 membrane fusion proteins from a native state to a trimer-of-hairpins structure promotes entry of viruses into cells. Here we present the structure of the bovine leukaemia virus transmembrane glycoprotein (TM) and identify a group of asparagine residues at the membrane-distal end of the trimer-of-hairpins that is strikingly conserved among divergent viruses. These asparagines are not essential for surface display of pre-fusogenic envelope. Instead, substitution of these residues dramatically disrupts membrane fusion. Our data indicate that, through electrostatic interactions with a chloride ion, the asparagine residues promote assembly and profoundly stabilize the fusion-active structures that are required for viral envelope-mediated membrane fusion. Moreover, the BLV TM structure also reveals a charge-surrounded hydrophobic pocket on the central coiled coil and interactions with basic residues that cluster around this pocket are critical to membrane fusion and form a target for peptide inhibitors of envelope function. Chargesurrounded pockets and electrostatic interactions with small ions are common among class-1 fusion proteins, suggesting that small molecules that specifically target such motifs should prevent assembly of the trimer-of-hairpins and be of value as therapeutic inhibitors of viral entry.">
    <entity charOffset="43-51" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e0" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="218-230" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e1" ontology_id="CHEBI_17089" text="glycoprotein" type="chemical"/>
    <entity charOffset="260-270" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e2" ontology_id="CHEBI_17196" text="asparagine" type="chemical"/>
    <entity charOffset="615-623" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e3" ontology_id="CHEBI_17996" text="chloride" type="chemical"/>
    <entity charOffset="633-643" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e4" ontology_id="CHEBI_17196" text="asparagine" type="chemical"/>
    <entity charOffset="939-946" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e5" ontology_id="CHEBI_33731" text="cluster" type="chemical"/>
    <entity charOffset="1020-1027" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e6" ontology_id="CHEBI_16670" text="peptide" type="chemical"/>
    <entity charOffset="1028-1038" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e7" ontology_id="CHEBI_35222" text="inhibitors" type="chemical"/>
    <entity charOffset="1128-1132" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e8" ontology_id="CHEBI_24870" text="ions" type="chemical"/>
    <entity charOffset="1165-1173" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e9" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="1197-1206" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e10" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="1325-1335" id="b708da1945a7a42cd61526e043d527592d4d9518.c1.e11" ontology_id="CHEBI_35222" text="inhibitors" type="chemical"/>
  </chunk>
</document>
